INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAC2 Class: NOTE 3.500% 2/1

Graham Capital Management, L.P.'s Holding History (CIK: 0001315421)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 4,500,000 Value ($000) $4,337 Avg Close — Range —
Q1 2023
Shares 4,500,000 Value ($000) $4,669 Avg Close — Range —
Q4 2022
Shares 5,747,000 Value ($000) $5,883 Avg Close — Range —